We Need Stronger Regulations To Improve Animal Treatment

In 1985, Congress amended the Animal Welfare Act to recognize two basic facts of life: that dogs need exercise and that primates have psychological needs in addition to physical ones. Any self-respecting ethologist would, of course, argue that all mammalian species have these needs. Yet three years later, these amendments have not been put into effect. Organized science has once again gotten in the way, raising such a storm of protest that proposed regulations have been held up. Scientists w

Written byNeal Barnard
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In 1985, Congress amended the Animal Welfare Act to recognize two basic facts of life: that dogs need exercise and that primates have psychological needs in addition to physical ones. Any self-respecting ethologist would, of course, argue that all mammalian species have these needs.

Yet three years later, these amendments have not been put into effect. Organized science has once again gotten in the way, raising such a storm of protest that proposed regulations have been held up. Scientists would have us believe that improving the lot of experimental animals is raising the costs of research so high that vitally important medical studies are coming to a screeching halt. The underlying assumption is that while animals are complex enough to be models for sophisticated research, they have no basic needs. In other words, if recognizing that the world is round costs us money, then flat will do.

This is but ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies